Rx Item-Calcipotriene-Betamethaso 0.005/.064 Ointment 60gm By Perrigo Pharma

TACLONEX- calcipotriene hydrate and betamethasone dipropionate suspension
LEO Pharma Inc.
INDICATIONS AND USAGE
Taclonex� Topical Suspension is indicated for the topical treatment of:
Plaque psoriasis of the scalp and body in patients 18 years and older
Plaque psoriasis of the scalp in patients 12 to 17 years
Bottle: Instruct patients to shake bottle prior to using Taclonex� ?Topical Suspension and to wash their hands after applying the product.
Applicator: Instruct patients to wash their hands if they get Taclonex� ?Topical Suspension on their fingers.
Apply Taclonex� Topical Suspension to affected areas once daily for up to 8 weeks. Therapy should be discontinued when control is achieved.
Patients 18 years and older should not use more than 100 g per week and patients 12 to 17 years should not use more than 60 g per week.
Taclonex� Topical Suspension should not be used with occlusive dressings unless directed by a physician. Taclonex�Topical Suspension is not for oral, ophthalmic, or intravaginal use. Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site.
Topical Suspension, 0.005%/0.064%
Each gram of Taclonex� Topical Suspension contains 52.18 mcg of calcipotriene hydrate (equivalent to 50 mcg of calcipotriene) and 0.643 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone). Taclonex�Topical Suspension is a viscous, nearly odorless, almost clear, colorless to slightly off-white suspension.
Applicator: After priming, each full actuation delivers a consistent amount of Taclonex� ? Topical Suspension.
Safety and effectiveness of the use of Taclonex� Topical Suspension in pediatric patients under the age of 12 years have not been established.
5.5 Eye Irritation
Avoid eye exposures. Taclonex� Topical Suspension may cause eye irritation.
5.6 Risk of Ultraviolet Light Exposures
Patients who apply Taclonex� Topical Suspension to exposed skin should avoid excessive exposure to either natural or artificial sunlight, including tanning booths, sun lamps, etc. Physicians may wish to limit or avoid use of phototherapy in patients who use Taclonex� Topical Suspension.

Rx Item-Calcipotriene-Betamethaso 0.005/
Item No.: RX284372/M NDC No.45802098996 UPC No.:345802989963 NDC No.45802-0989-96 UPC/GTIN No.3-45802-98996-3 MPN No. 98996 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.

Perrigo Co
BRAND: CALCIPOTRIENE-BETAMETHASONE NDC: 45802-0989-96,45802098996 UPC: 3-45802-98996-3,345802989963

Click above for Brand
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.